×
For best experience we recommend to activate Javascript in your browser.
Recombinant Thymic Stromal Lymphopoietin antibody
The Human Monoclonal anti-Thymic Stromal Lymphopoietin antibody (Clone 7G4) (ABIN7797343) specifically detects Thymic Stromal Lymphopoietin in ELISA.
The antibody is reactive with Human samples.
Catalog No. ABIN7797343
$392.70
$462.00
save $69.30 (-15 %)
Plus shipping costs $50.00
Delivery in 13 to 16 Business Days
Quick Overview for Recombinant Thymic Stromal Lymphopoietin antibody (ABIN7797343)
Target
See all Thymic Stromal Lymphopoietin (TSLP) Antibodies
Thymic Stromal Lymphopoietin (TSLP)
Antibody Type
Recombinant Antibody
Reactivity
All reactivities for Thymic Stromal Lymphopoietin antibodies
Human
Host
All hosts for Thymic Stromal Lymphopoietin antibodies
Human
Clonality
All clonalities for Thymic Stromal Lymphopoietin antibodies
Monoclonal
Conjugate
All conjugates for Thymic Stromal Lymphopoietin antibodies
This Thymic Stromal Lymphopoietin antibody is un-conjugated
Application
All applications for Thymic Stromal Lymphopoietin antibodies
ELISA
Clone
7G4
Product Details anti-Thymic Stromal Lymphopoietin Antibody
(hide)
Purpose
TSLP Recombinant Monoclonal Antibody
Purification
Affinity-chromatography
Immunogen
Recombinant Human TSLP protein
Isotype
IgG2
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Preservative: 0.03 % Proclin 300 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C,-80 °C
Storage Comment
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Target Details for Thymic Stromal Lymphopoietin
(hide)
Target
Thymic Stromal Lymphopoietin (TSLP)
Alternative Name
TSLP
Background
Thymic stromal lymphopoietin, TSLP
UniProt
Q969D9
Recently viewed
(hide)
Chat with us , powered by LiveChat